Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sam Grigg, Paul Gow & Neville Yeomans. (2020) Sirolimus in Liver Transplant Recipients With Hepatocellular Carcinoma. Journal of Investigative Surgery 33:4, pages 389-390.
Read now
Read now
Articles from other publishers (16)
T. Winans, Z. Oaks, G. Choudhary, A. Patel, N. Huang, T. Faludi, D. Krakko, J. Nolan, J. Lewis, Sarah Blair, Z. Lai, S.K. Landas, F. Middleton, J.M. Asara, S.K. Chung, B. Wyman, P. Azadi, K. Banki & A. Perl. (2023) mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency. Journal of Autoimmunity 140, pages 103112.
Crossref
Crossref
D Maroeska WM te Loo, Veroniek Harbers, Lars Vermeltfoort & Marieke JH Coenen. (2023) Influence of genetic variants on the pharmacokinetics and pharmacodynamics of sirolimus: a systematic review. Pharmacogenomics.
Crossref
Crossref
Sophie Kollbeck, Julia-Kristin Graß, Jens Georg Hillingsø & Luit Penninga. (2023) De novo mTOR inhibitor immunosuppression versus calcineurin inhibitor immunosuppression for liver transplant recipients. Cochrane Database of Systematic Reviews 2023:8.
Crossref
Crossref
Gongming Zhang, Binwei Duan & Guangming Li. (2022) mTORi‐based immunosuppression reduces HCC recurrence at the expense of increased adverse side effects: A systematic review and meta‐analysis. Clinical Transplantation 36:12.
Crossref
Crossref
Christopher J. Danford & Richard Gilroy. (2022) Mammalian Target of Rapamycin and Hepatocellular Carcinoma: The Question's Always There, Until We Choose To Answer It. Liver Transplantation 28:6, pages 931-932.
Crossref
Crossref
Xiangyu Yan, Songhan Huang, Yang Yang, Ziwen Lu, Feiyu Li, Liyong Jiang, Yong Jiang & Jun Liu. (2022) Sirolimus or Everolimus Improves Survival After Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis. Liver Transplantation 28:6, pages 1063-1077.
Crossref
Crossref
Ren-Yi Su, Sun-Bin Ling, Qiao-Nan Shan, Xu-Yong Wei, Rui Wang, Chang-Ku Jia, Li Zhuang, Tian Shen, Li-Min Ding, Zhi-Dan Xu, Lai-Bang Luo, Li-Bo Sun, Guang-Ming Li, Tai-Shi Fang, Nan Jiang, Kun Zhang, Zhao-Jie Su, Zhi-Hai Peng, Ren Lang, Tao Jiang, Qiang He, Lin-Sen Ye, Yang Yang, Yu-Ting He, Wen-Zhi Guo, Liu-Gen Lan, Xu-Yong Sun, Dong Chen, Zhi-Shui Chen, Da-Wei Zhou, Shao-Jun Ye, Qi-Fa Ye, Min Tian, Jian-Hua Shi, Bo Wang, Jiang Liu, Qian Lu, Wei Rao, Jin-Zhen Cai, Tao Lv, Jia-Yin Yang, Pu-Sen Wang, Lin Zhong, Jing-Sheng Ma, Qi-Gen Li, Sheng-Dong Wu, Chang-Jiang Lu, Cai-De Lu, Dong-Hua Zhang, Xuan Wang, Zi-Qiang Li, Mu-Jian Teng, Jun-Jie Li, Wen-Tao Jiang, Jian-Hua Li, Quan-Bao Zhang, Ning-Qi Zhu, Zheng-Xin Wang, Kang He, Qiang Xia, Shao-Hua Song, Zhi-Ren Fu, Wei Qiu, Guo-Yue Lv, Rui-Peng Song, Ji-Zhou Wang, Zheng Wang, Jian Zhou, Gang Chen, Ying-Peng Zhao, Li Li, Ze-Min Hu, Qi-Jie Luo, Zhong-Zhou Si, Bin Xie, Xiao-Shun He, Zhi-Yong Guo, Shu-Sen Zheng & Xiao Xu. (2022) Efficacy and safety of sirolimus early conversion protocol in liver transplant patients with hepatocellular carcinoma: A single-arm, multicenter, prospective study. Hepatobiliary & Pancreatic Diseases International 21:2, pages 106-112.
Crossref
Crossref
Qianwei Ye, Sunbin Ling, Guangjiang Jiang, Qiaonan Shan, Shengjun Xu, Qifan Zhan, Yifeng Wu, Yuchen Liu, Shusen Zheng & Xiao Xu. (2021) Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria. European Journal of Surgical Oncology 47:10, pages 2533-2542.
Crossref
Crossref
Tao Wang, Qiting Zhang, Ning Wang, Ziqi Liu, Bin Zhang & Yufen Zhao. (2021) Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma. Current Medicinal Chemistry 28:16, pages 3107-3146.
Crossref
Crossref
María Tristán-Manzano, Pedro Justicia-Lirio, Noelia Maldonado-Pérez, Marina Cortijo-Gutiérrez, Karim Benabdellah & Francisco Martin. (2020) Externally-Controlled Systems for Immunotherapy: From Bench to Bedside. Frontiers in Immunology 11.
Crossref
Crossref
Xiao Chen, Dong-Dong Wang, Hong Xu & Zhi-Ping Li. (2020) Initial dose recommendation for sirolimus in paediatric kaposiform haemangioendothelioma patients based on population pharmacokinetics and pharmacogenomics. Journal of International Medical Research 48:8, pages 030006052094762.
Crossref
Crossref
Dong-Dong Wang, Xiao Chen, Hong Xu & Zhi-Ping Li. (2020) Initial Dosage Recommendation for Sirolimus in Children With Tuberous Sclerosis Complex. Frontiers in Pharmacology 11.
Crossref
Crossref
Marina Berenguer, Patrizia Burra, Mark Ghobrial, Taizo Hibi, Herold Metselaar, Gonzalo Sapisochin, Sherrie Bhoori, Nancy Kwan Man, Valeria Mas, Masahiro Ohira, Bruno Sangro & Luc J.W. van der Laan. (2020) Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference. Transplantation 104:6, pages 1143-1149.
Crossref
Crossref
Kin Pan Au & Kenneth Siu Ho Chok. (2018) Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm. World Journal of Gastroenterology 24:45, pages 5081-5094.
Crossref
Crossref
Jürgen M. Kolos, Andreas M. Voll, Michael Bauder & Felix Hausch. (2018) FKBP Ligands—Where We Are and Where to Go?. Frontiers in Pharmacology 9.
Crossref
Crossref
Sam Grigg, Paul J. Gow & Neville Yeomans. (2018) Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 48:11-12, pages 1330-1331.
Crossref
Crossref